Expertise in
6
conditions

Michelle M. Mezei

Vancouver, BC, CA 
Expertise in
6
conditions
Vancouver, BC, CA 

Overview

Michelle Mezei practices practicing medicine in Vancouver, Canada.

Ms. Mezei is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Multiple Symmetric Lipomatosis, Progressive External Ophthalmoplegia, Thymic Epithelial Tumor, Familial Multiple Lipomatosis, and Thymectomy.

She is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Vancouver, BC, Canada
Other Locations
Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Trial)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Trial)
Enrollment Status: Withdrawn
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: AG10
Study Phase: Phase 3
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 24 Weeks Treatment With REN001 in Patients With Primary Mitochondrial Myopathy
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 24 Weeks Treatment With REN001 in Patients With Primary Mitochondrial Myopathy
Enrollment Status: Completed
Publish Date: May 08, 2024
Intervention Type: Drug
Study Drug: REN001
Study Phase: Phase 2
View 1 Less Clinical Trial

27 Total Publications

A Network Meta-Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs.
A Network Meta-Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs.
Journal: European journal of neurology
Published: July 03, 2026

Frequently Asked Questions about Michelle M. Mezei

Is Michelle M. Mezei a top-rated expert for Multiple Symmetric Lipomatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Michelle M. Mezei is classified as an Advanced expert for Multiple Symmetric Lipomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michelle M. Mezei participate in research or clinical trials?

Yes. Michelle M. Mezei has published 27 articles and abstracts on conditions like Multiple Symmetric Lipomatosis. You can view a list of Michelle M. Mezei's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mezei's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile